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EvaluaSon of the quality of nebulizer home maintenance by adult 
patients 
S. Gardes 2, I. Duperr ay 2, P. Ferr arese 9, C. Chabloz 1
~MedicaI Information Department, Hospices Civils de Lyon, France. ~Adult CF 
Unit, HbpitaI Lyon Sud, France 
Agreed steps of inhaled therapy material maintenance onsist ha cleaning after each 
use plus every day disinfection, both according to specific procedures. Objectives: 
to evaluate the proportion of trained patients for the maintenance techniques, and 
the quality of both cleaning and disinfection performed at home. Method: the nurse 
practitioner of the CF unit systematically interviewed the patients coming for a 
rout ine control between March and October 2004, fo l lowing a standard 
questionnaire. The questions were about the medicine used during the inhaled 
treatment, the kind of equipment, and the frequency and steps of the maintenance. 
Results: 60 patients had been interviewed. Medicine used by inhalation was alpha 
dornase for 62%, colistine for 46%, tobramycine for 32%. budesonide and 
acety lcysteine were used by 5% or less of our population. 16% of patients used only 
disposable material, the remaining 84% were supposed to maintain their equipment. 
65% of the patients using non disposable material cleaned it after each use, 29% of 
whom with appropriate methods. 8% never cleaned it. Concerning the disinfection 
step, 68 % performed it, from whom 38% once a day. 29% of the patients proceeded 
appropriately with frequency and steps of disinfection. Only 1 patient correctly 
conducted every steps of the inhaled therapy material maintenance. 9% of the 
patients had been trained for the maintenance steps and techniques. No significant 
statistical relationship was observed between quality of maintenance mad training, 
although 50% of the trained patients performed correct cleaning versus only 12% of 
the non trained. Conclusion: appropriate training mad use of disposable material are 
recommended to reduce hazardous practices. 
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Central venous access device (CVAD) sampling of serum 
aminoglycoside levels compared with venous sampling in adults with 
cystic fibrosis 
C. Evmas, R. Davies, J. Whitehouse, D. Honeybourne 
West Midla~uls Adult Cystic Fibrosis Centre. Bi mingham Heartla~uls wM SolihulI 
NHS Trust, U.K. 
Vigorous treatment of respiratory tract infections with intravenous antibiotics 
requires venous access. The use of CVADs to provide venous access to administer 
drugs is commonplace, however peripheral blood sampling is still necessary. 
Obtaining peripheral blood can often be difl3cult due to damaged veins from many 
years of cannulation and phlebotomy. The aim of the study was to compare central 
versus peripheral aminoglycoside lev ls and to ascertain i f patients preferred CVAD 
sampling. 
A comparison design was used to compare peak and trough aminoglycoside levels. 
The peripheral sample was obtained first, immediately followed by the CVAD 
sample. The aminoglycoside was administered and blood withdrawn 1 hour later 
from both sites to obtain a peak level. Both blood samples were analysed. Patients 
then completed a sell 'administered questionnaire. 
20 patients were recruited. Blood could not be drawn from CVADs in 4 patients. 
Peripheral and CVAD samples were compared in 16 patients. Of  the CVAD trough 
samples 31%(5) were greater than 2mmols/l  (normal range 0 2mmols/l). 94%(15) 
of peripheral trough samples were within the normal range. 63%(10) of the CVAD 
trough levels were higher than the peripheral trough levels. 
6% (1) of the CVAD peak levels were greater than 12mmol/l  (normal range 8 
12mmol/l). No peripheral aminoglycoside levels were greater then 12mmol/l. 
44%(7) of the CVAD peak levels were higher than peripheral samples. Patients 
reported a preference for blood samples to be taken from the CVAD. 
I f  CVAD monitor ing alone had been used, 5 patients would  have had 
inappropriately altered aminoglycoside doses. Results show that peripheral and 
CVAD aminoglycoside samples are not always comparable. 
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The need of monitoring serum levels of aminoglycosides during 
intravenous keabnent at home 
D.H.M. vma Elst Lauri j  sen, F. Teding vma Bet ldaout 
Cystic Fibrosis Center Ut echt, Department ofPulmonology, University Medical 
Centre Utrecht, The Netherla~Ms 
Introduct ion:  ha C~Jstic Fibrosis patients intravenous aminoglycosid (tobramycin) 
combined with a [3 lactam is an effective treatment for respiratory infections due to 
Pseudomonas aemginosa IV treatment at home is an altemative for in hospital 
treatment. 
During a 3 days admission in hospital, tobramycin levels are determined and 
tobramycin dosing is adjusted. Further treatment is completed at home, in about 14 
days. 
A im:  To examine whether monitoring of t obr amycin serum levels during treatment 
at home is useful. 
Methods:  At  least seven days after discharge from hospital, serum concentrations 
of tobramycin were determined from patients who were on intravenous home 
treatment. 
ha a twice daily dosage regime peak levels between 10 and 18 mg/l are considered 
to be effective and trough levels < 1 mg/l are supposed to be non toxic. 
ResuRs: From 14 patients in home treatment 25 trough serum levels were 
determined and 18 peak levels. 
The tobramycin trough levels ranged from 0.2 mg/l to 13 mg/l, from which 4 
patients (16%) reached levels > 1.0 mg/l (range 1.9 13.0 mg/l). 
ha total 8 peak levels (44%) deviated from the al lowed range; 6 peak levels (33%) 
were < 10 mg/l (range 4.0 8.0 mg/l), 2 peak levels (11%) were > 18.0 mg/l (20.0; 
36.0 mg/l) 
Conclusions:  Serum levels of tobramycin from CFpat ients  who complete 
intravenous treatment at home, are regularly out of range, so monitoring of serum 
concentrations has to be continued after discharge from hospital. The nurse 
practitioner has a specific role in this monitoring. 
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The contribution of specialist nurses to the management of cystic 
fibrosis: parents' and children's perspectives 
E. Savage 
School of Nursing & Midwifery, University College Corl~, Irela~ul 
Aim:  The aim of this paper is to examine the contribution of specialist nurses to the 
multidisciplinary mmmgement of cystic fibrosis (CF) from the perspectives of 
children and their parents. Although it has been reported that nurses are key 
professionals in supporting families cope with their chronic illness experiences of 
CF (Whyte 1994), there has been little exploration of the contribution of nurses in 
facil itating parents and children's day to day mmmgement of CF and of how this 
contribution differs from that of other professionals. 
Methods:  Thirty two children aged 6 to 14 years, and their parents participated ha 
this study. Methods of data collection were tape recorded interviews, participant 
observation at outpatient clinics, and a review of case notes. Data were collected 
and mmlyzed conctarently using a method of constant comparison, and theoretical 
sampling was used to further explore and develop emergent themes. 
Results: Children and parents described specialist nurses as making ma important 
contribution to helping them mmmge CF. Dist inguishing features of the contribution 
of nurses compared to other professionals included accessibility, personal 
relationships with them, their 'expert' lmowledge, and their attention to emotional 
mad social care. However,  the orgmfizational context of mult idiscipl inary 
consultations and their biomedical focus of care were seen to inhibit the 
contribution of nurses in meeting the particular needs of children and their parents. 
Condus lon:  The findings highlight a need for CF multidisciplinary teams to 
critically review their consultation practices o that specialist nurses cma address the 
particular challenges mad difficulties that parents' and children's face ha the day to 
day practicalities of mmmging CF. 
